A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation

BACKGROUND: Targeted therapy has been proven to be effective in lung cancer patients with specific driver gene mutations. At present, Sanger sequencing is still the gold standard in clinical practice to detect mutation, and amplification refractory mutation system PCR (ARMS-PCR) has become widely us...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ling, Wang, Weidong, Wang, Fang, Zhang, Rusi, Zhang, Lanjun, Qi, Huiwei, Gu, Weiquan, Zhou, Ningning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797359/
https://www.ncbi.nlm.nih.gov/pubmed/35117013
http://dx.doi.org/10.21037/tcr.2019.10.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797359/
https://www.ncbi.nlm.nih.gov/pubmed/35117013
http://dx.doi.org/10.21037/tcr.2019.10.37

Ejemplares similares